NOVOFINE PLUS 32G
Device
Novo Nordisk Inc
Total Payments
$437,942
Transactions
14
Doctors
0
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $437,942 | 14 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $437,942 | 14 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ISS-001415 | Novo Nordisk Inc | $363,744 | 0 |
| ISS-001391 | Novo Nordisk Inc | $68,596 | 0 |
| ISS-001385 | Novo Nordisk Inc | $3,345 | 0 |
| ISS-001421 | Novo Nordisk Inc | $916.00 | 0 |
| NN1250-4511 | Novo Nordisk AS | $596.97 | 0 |
| ISS-001379 | Novo Nordisk Inc | $572.50 | 0 |
| ISS-001493 | Novo Nordisk Inc | $171.75 | 0 |
Top Doctors Receiving Payments for NOVOFINE PLUS 32G
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Seattle, WA | $437,942 | 14 |
Ad
Manufacturing Companies
- Novo Nordisk Inc $437,345
- Novo Nordisk AS $596.97
Product Information
- Type Device
- Total Payments $437,942
- Total Doctors 0
- Transactions 14
About NOVOFINE PLUS 32G
NOVOFINE PLUS 32G is a device associated with $437,942 in payments to 0 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk Inc.
Payment data is available from 2024 to 2024. In 2024, $437,942 was paid across 14 transactions to 0 doctors.
The most common payment nature for NOVOFINE PLUS 32G is "Unspecified" ($437,942, 100.0% of total).
NOVOFINE PLUS 32G is associated with 7 research studies, including "ISS-001415" ($363,744).